Abstract:Docetaxel (DTX) is classified as a class IV drug that exhibits poor aqueous solubility (6–7 μg/mL in water) and permeability (P-glycoprotein substrate). The main objective of this study was to construct, characterize, and evaluate docetaxel loaded nanomicellar formulation in vitro for oral delivery to enhance the absorption and bioavailability of DTX, as well as to circumvent P-gp efflux inhibition. Formulations were prepared with two polymeric surfactants, hydrogenated castor oil-40 (HCO-40) and D-α-Tocopherol polyethylene glycol 1000 succinate (VIT E TPGS) with solvent evaporation technique, and the resulting DTX nanomicellar formulations were characterized by proton nuclear magnetic resonance spectroscopy (1H NMR), Fourier Transform Infrared Spectroscopy (FT–IR), X-ray powder diffraction (XRD), and transmission electron microscopy (TEM). Proton NMR, FT–IR, and XRD data indicated that DTX was completely encapsulated within the hydrophobic core of the nanomicelles in its amorphous state. TEM data revealed a smooth spherical shape of the nanomicellar formulation. The optimized formulation (F-2) possessed a mean diameter of 13.42 nm, a zeta potential of −0.19 mV, with a 99.3% entrapment efficiency. Dilution stability study indicated that nanomicelles were stable up to 100-fold dilution with minimal change in size, poly dispersity index (PDI), and zeta potential. In vitro cytotoxicity study revealed higher anticancer activity of DTX nanomicelles at 5 μM compared to the native drug against breast cancer cell line (MCF-7) cells. The LC–MS data confirmed the chemical stability of DTX within the nanomicelles. In vitro drug release study demonstrated faster dissolution of DTX from the nanomicelles compared to the naked drug. Our experimental results exhibit that nanomicelles could be a drug delivery system of choice to encapsulate drugs with low aqueous solubility and permeability that can preserve the stability of the active constituents to provide anticancer activity.

Synthesis of Calcium Phosphate Nanoparticle‐Based Docetaxel Delivery System and Its in Vitro Anticancer Activity

Polydopamine-Functionalized CA-(PCL-ran-PLA) Nanoparticles for Target Delivery of Docetaxel and Chemo-photothermal Therapy of Breast Cancer.

Calcium Phosphate Hybrid Nanoparticles: Self-Assembly Formation, Characterization, and Application As an Anticancer Drug Nanocarrier

Docetaxel‐Loaded Nanoparticles of Dendritic Amphiphilic Block Copolymer H40‐PLA‐b‐TPGS for Cancer Treatment

Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel.

Enhanced Antitumor Efficacy, Biodistribution and Penetration of Docetaxel-Loaded Biodegradable Nanoparticles.

How Nanotechnology Can Enhance Docetaxel Therapy

Reduction-Responsive Docetaxel Prodrug Encapsulated Within Human Serum Albumin Nanoparticles for Cancer Therapy.

Co-delivery of docetaxel and bortezomib based on a targeting nanoplatform for enhancing cancer chemotherapy effects.

Robust Aptamer-Polydopamine-Functionalized M-Plga-Tpgs Nanoparticles for Targeted Delivery of Docetaxel and Enhanced Cervical Cancer Therapy

Advances in nano-drug delivery systems for docetaxel

Docetaxel-loaded PAMAM-based Poly (Γ-Benzyl-l-glutamate)-b-d-α-tocopheryl Polyethylene Glycol 1000 Succinate Nanoparticles in Human Breast Cancer and Human Cervical Cancer Therapy.

Nitric oxide-releasing docetaxel prodrug nanoplatforms for effective cancer therapy

Antitumor efficiency of D-alpha-tocopheryl polyethylene glycol 1000 succinate-b-poly(epsilon-caprolactone-ran-lactide) nanoparticle-based delivery of docetaxel in mice bearing cervical cancer.

Antitumor Efficiency of D-α-Tocopheryl Polyethylene Glycol 1000 Succinate-b-Poly(ε-caprolactone-<I>ran</I>-lactide) Nanoparticle-Based Delivery of Docetaxel in Mice Bearing Cervical Cancer

Self-Assembled Nanomicellar Formulation of Docetaxel as a Potential Breast Cancer Chemotherapeutic System

Docetaxel-Loaded-Lipid-Based-Nanosuspensions (Dtx-Lns): Preparation, Pharmacokinetics, Tissue Distribution and Antitumor Activity

Preparation and in vitro evaluation of active targeting pH-responsive nanoparticles for breast cancer

NGR-modified Ph-Sensitive Liposomes for Controlled Release and Tumor Target Delivery of Docetaxel.

<sub>3</sub><sub>1</sub> Integrin-Targeting Polymersomal Docetaxel as an Advanced Nanotherapeutic for Nonsmall Cell Lung Cancer Treatment

Redox-responsive Nanoparticles Based on Chondroitin Sulfate and Docetaxel Prodrug for Tumor Targeted Delivery of Docetaxel.